Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Models to study basic and applied aspects of lysosomal storage disorders
Ángel Gaudioso, Teresa P. Silva, María Dolores Ledesma
Advanced Drug Delivery Reviews (2022) Vol. 190, pp. 114532-114532
Open Access | Times Cited: 10

Showing 10 citing articles:

Overcoming biological barriers by virus-like drug particles for drug delivery
Yu‐Ling Chen, Chun‐Jie Bao, Jia‐Lun Duan, et al.
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115134-115134
Closed Access | Times Cited: 19
Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders
Marina Placci, Marina I. Giannotti, Silvia Muro
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114683-114683
Open Access | Times Cited: 17
A Multi-Omics-Empowered Framework for Precision Diagnosis and Treatment of Lysosomal Diseases
Nguyen Thi Hai Yen, Nguyen Tran Nam Tien, Nguyen Quang Thu, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101274-101274
Open Access
Insights into 2D and 3D cell culture models for nanoparticle-based drug delivery to glioblastoma
Girstautė Dabkevičiūtė, Vilma Petrikaitė
Biochemical Pharmacology (2025), pp. 116931-116931
Closed Access
Differential sensitivity of hemocyte subpopulations (Mytilus edulis) to aged polyethylene terephthalate micro- and nanoplastic particles
Jenevieve Hara, Maaike Vercauteren, Sébastjen Schoenaers, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 286, pp. 117255-117255
Open Access | Times Cited: 3
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
Nuria Gómez-Cebrián, Elena Gras‐Colomer, José Luís Poveda Andrés, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1159-1159
Open Access | Times Cited: 4
Lysosomal therapies and drug delivery strategies: An overview
Silvia Muro
Advanced Drug Delivery Reviews (2023) Vol. 202, pp. 115112-115112
Open Access | Times Cited: 3
Endocannabinoid receptor 2 is a potential biomarker and therapeutic target for the lysosomal storage disorders
Calogera M. Simonaro, Makiko Yasuda, Edward H. Schuchman
Journal of Inherited Metabolic Disease (2024)
Open Access
Newborn Screening of 6 Lysosomal Storage Disorders by Tandem Mass Spectrometry
Yao Chen, Yan Yang, Yinglin Zeng, et al.
Clinical Pediatrics (2023) Vol. 63, Iss. 10, pp. 1364-1370
Closed Access | Times Cited: 1
CLN3 clinches lysosomes in clearance of glycerophospholipids
Guang Lu, Han‐Ming Shen
Life Metabolism (2022) Vol. 2, Iss. 1
Open Access
Page 1

Scroll to top